DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease
Fatty liver disease is one of the most prevalent forms of chronic liver disease that encompasses both alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD). Alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH) are intermediate stages of ALD and NAFLD, which can progress to more advanced forms, including cirrhosis and hepatocellular carcinoma. Oxidative stress and particularly alterations in mitochondrial function are thought to play a significant role in both ASH and NASH and recognized to contribute to the generation of reactive oxygen species (ROS), as documented in experimental models. Despite the evidence of ROS generation, the therapeutic efficacy of treatment with antioxidants in patients with fatty liver disease has yielded poor results. Although oxidative stress is considered to be the disequilibrium between ROS and antioxidants, there is evidence that a subtle balance among antioxidants, particularly in mitochondria, is necessary to avoid the generation of ROS and hence oxidative stress. Conclusion: As mitochondria are a major source of ROS, the present review summarizes the role of mitochondrial oxidative stress in ASH and NASH and presents emerging data indicating the need to preserve mitochondrial antioxidant balance as a potential approach for the treatment of human fatty liver disease, which may pave the way for the design of future trials to test the therapeutic role of antioxidants in fatty liver disease., Supported by the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health (P50AA011999). We acknlowledge the
support from grants SAF2014-57674-R, SAF2015-69944R and SAF2017-85877R from Plan Nacionald de I+D, by the CIBEREHD from the
Instituto de Salud Carlos III, by the AGAUR of Generalitat de Catalunya SGR-2017-1112, by the FUNDACION BBVA and by the European
Cooperation in Science and Technology (COST) ACTION 17112 Prospective European Drug-Induced Liver Injury Network, Peer reviewed
Proyecto:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2014-57674-R
,
MINECO SAF2015-69944-R
,
AEI SAF2017-85877-R
DOI: http://hdl.handle.net/10261/397024, https://api.elsevier.com/content/abstract/scopus_id/85064461526
HANDLE: http://hdl.handle.net/10261/397024, https://api.elsevier.com/content/abstract/scopus_id/85064461526